1. Home
  2. FTK vs ACET Comparison

FTK vs ACET Comparison

Compare FTK & ACET Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Flotek Industries Inc.

FTK

Flotek Industries Inc.

HOLD

Current Price

$20.42

Market Cap

522.1M

Sector

Industrials

ML Signal

HOLD

Logo Adicet Bio Inc.

ACET

Adicet Bio Inc.

HOLD

Current Price

$7.81

Market Cap

77.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FTK
ACET
Founded
1985
1947
Country
United States
United States
Employees
N/A
N/A
Industry
Major Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
522.1M
77.3M
IPO Year
1997
2017

Fundamental Metrics

Financial Performance
Metric
FTK
ACET
Price
$20.42
$7.81
Analyst Decision
Buy
Strong Buy
Analyst Count
1
3
Target Price
$20.00
$48.33
AVG Volume (30 Days)
241.4K
83.4K
Earning Date
05-05-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
147.06
N/A
EPS
0.12
N/A
Revenue
$136,092,000.00
N/A
Revenue This Year
$13.33
N/A
Revenue Next Year
$16.38
N/A
P/E Ratio
$169.54
N/A
Revenue Growth
214.53
N/A
52 Week Low
$10.96
$0.46
52 Week High
$20.73
$9.05

Technical Indicators

Market Signals
Indicator
FTK
ACET
Relative Strength Index (RSI) 70.00 50.58
Support Level $15.20 $7.50
Resistance Level N/A $8.68
Average True Range (ATR) 1.30 0.53
MACD 0.34 -0.10
Stochastic Oscillator 87.77 42.82

Price Performance

Historical Comparison
FTK
ACET

About FTK Flotek Industries Inc.

Flotek Industries Inc is a technology-driven specialty chemistry and data company. It has two reportable segments: Its Chemistry Technologies segment includes specialty chemistries, logistics and technology services. It also include integrated oil and gas companies, oilfield services companies, independent oil and gas companies, national and state-owned oil companies, and international supply chain management companies. The Data Analytics segment provides analytical measurement solutions and deliver real-time information and insights to customers to enable optimization of operations and reduction of emissions and their carbon intensity. Key revenue comes from its Chemistry Technologies segment.

About ACET Adicet Bio Inc.

Adicet Bio Inc is a clinical-stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer. It is advancing a pipeline of off-the-shelf gamma delta T cells, engineered with chimeric antigen receptors (CARs), to facilitate durable activity in patients. The company's main product candidate, prulacabtagene leucel (prula-cel), is an allogeneic gamma delta T cell therapy expressing a CAR targeting CD20, and is being developed for the potential treatment of autoimmune diseases. Additionally, it is pursuing ADI-212, a next-generation gene-edited and armored clinical candidate designed to target prostate-specific membrane antigen (PSMA).

Share on Social Networks: